CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-05 | Saad Mark E Director | Sale 10b5-1 | −9,127 | $125.07 | $1.1M | 10,002 |
| 2025-09-05 | Saad Mark E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,127 | 0 | ||
| 2025-09-02 | JEFFS ROGER Director | Sale 10b5-1 | −13,464 | $123.68 | $1.7M | 57,510 |
| 2025-08-29 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $121.27 | $2.4M | 70,974 |
| 2025-08-28 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $121.60 | $2.4M | 90,974 |
| 2025-08-27 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $122.30 | $2.4M | 110,974 |
| 2025-08-26 | JEFFS ROGER Director | Sale 10b5-1 | −20,000 | $120.03 | $2.4M | 130,974 |
| 2025-08-22 | JEFFS ROGER Director | Sale 10b5-1 | −16,694 | $120.08 | $2.0M | 150,974 |
| 2025-06-23 | Murdock Hunter R. General Counsel | Option exercise 10b5-1 | +6,014 | $29.91 | $180K | 6,014 |
| 2025-06-23 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −6,014 | $100.12 | $602K | 0 |
| 2025-06-23 | Murdock Hunter R. General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,014 | 16,369 | ||
| 2025-06-20 | Murdock Hunter R. General Counsel | Option exercise 10b5-1 | +7,500 | $29.91 | $224K | 7,500 |
| 2025-06-20 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $102.47 | $769K | 0 |
| 2025-06-20 | Murdock Hunter R. General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 22,383 | ||
| 2025-06-18 | Murdock Hunter R. General Counsel | Option exercise 10b5-1 | +7,500 | $29.91 | $224K | 7,500 |
| 2025-06-18 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $100.90 | $757K | 0 |
| 2025-06-18 | Murdock Hunter R. General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 29,883 | ||
| 2025-06-17 | Murdock Hunter R. General Counsel | Option exercise 10b5-1 | +7,500 | $29.91 | $224K | 7,500 |
| 2025-06-17 | Murdock Hunter R. General Counsel | Sale 10b5-1 | −7,500 | $100.26 | $752K | 0 |
| 2025-06-17 | Murdock Hunter R. General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 37,383 |
Page 8 of 22 · 422 trades